August 11, 2026
ALZAI Health Corp.
ISIN: CA02262P1036
ALZAI and Linus Health explore AI-driven collaborations aimed at early identification of Alzheimer’s disease risk and cognitive impairment
TORONTO, ONTARIO AND BOSTON, MASSACHUSETTS – August 11, 2026 – ALZAI Health Corp. (TSXV: ALZI) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with...
Read more >>ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology
TORONTO, ONTARIO – July 20, 2026 – ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into an exclusive worldwide license agreement (the "Agreement") with MOR Research Applications Ltd. ("MOR"), the technology transfer company of Clalit Health Services and Yeda Research, the...
Read more >ALZAI Health Corp. Signs Strategic U.S. Commercialization Agreement With Centauri Health Solutions to Advance AI-Driven Alzheimer’s Risk Identification
TORONTO, ONTARIO – July 2, 2026 - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into a strategic teaming agreement (the "Agreement") with Centauri Health Solutions ("Centauri"), a leading U.S. healthcare technology company serving 60 million members through advanced mission-critical technology,...
Read more >